An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institutes of Health)
A biochemistry researcher from the University of Miami Miller School of Medicine has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems. Nanoparticle drug delivery offers a new strategy for treating HIV-associated neurocognitive disorders, such as HIV dementia, which can be magnified by recreational drug use in HIV-positive individuals.
